{"schema_version":"secwatch.filing_event.v1","accession":"0001827090-24-000035","form_type":"8-K","ticker":"CERT","cik":"0001827090","company_name":"Certara, Inc.","filed_at":"2024-11-06T23:59:59+00:00","discovered_at":"2026-05-14T18:03:09.869766+00:00","generated_at":"2026-05-30T04:46:30.045933+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Certara Q3 rev $94.8M (+11% YoY); net loss narrows to $1.4M; guides FY24","bullets":["Revenue $94.8M (+11% YoY); software rev $35.9M (+15%), services rev $58.9M (+9%).","Net loss $1.4M vs $49.0M loss in Q3 2023; improvement driven by lower goodwill impairment.","Adjusted EBITDA $33.1M, up 15% from $28.8M in Q3 2023.","CEO cites Chemaxon acquisition closed; focus on integrating biosimulation platform.","Full-year 2024 financial guidance updated (specifics not provided in release snippet)."],"urls":{"canonical":"https://secwatch.observer/filing/0001827090-24-000035","json":"https://secwatch.observer/filing/0001827090-24-000035.json","markdown":"https://secwatch.observer/filing/0001827090-24-000035.md","text":"https://secwatch.observer/filing/0001827090-24-000035.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1827090/000182709024000035/0001827090-24-000035-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1827090/000182709024000035/certara-20241106.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-30T04:46:30.045933+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}